„First Line“

Suchergebnisse

3.416 Treffer

• Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy
  Jiang, Bei ; Dai, Qinghai ; Liu, Yamin ; Yu, Guangxin ; Mi, Yuqiang
• A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
  Takahara, Naminatsu ; Nakai, Yousuke ; Isayama, Hiroyuki ; Sasaki, Takashi ; Morine, Yuji ; Watanabe, Kazuo ; Ueno, Makoto ; Ioka, Tatsuya ; Kanai, Masashi ; Kondo, Shunsuke ; Okano, Naohiro ; Koike, Kazuhiko
• ChemInform Abstract: K (AsW 2 O 9), The First Member of the Arsenate—Tungsten Bronze Family: Synthesis, Structure, Spectroscopic and Non‐Linear Optical Properties.
  Alekseev, Evgeny V. ; et al., et al.
• Stability and Robustness Properties of Universal Adaptive Controllers for First Order Linear Systems
  Helmke, Uwe ; Prätzel-Wolters, Dieter 1987 Technische Universität Kaiserslautern, Fachbereich Mathematik
• Experimental Observation of Dirac Nodal Links in Centrosymmetric Semimetal TiB2
  Liu, Z. ; Lou, R. ; Guo, P. ; Wang, Q. ; Sun, S. ; Li, C. ; Thirupathaiah, S. ; Fedorov, A. ; Shen, D. ; Liu, K. 2018 College Park, MD : American Physical Society
• The 16th Data Release of the Sloan Digital Sky Surveys: First Release from the APOGEE-2 Southern Survey and Full Release of eBOSS Spectra
  Ahumada, Romina ; Prieto, Carlos Allende ; Almeida, Andrés ; Anders, Friedrich ; Anderson, Scott F. ; Andrews, Brett H. ; Anguiano, Borja ; Arcodia, Riccardo ; Armengaud, Eric ; Aubert, Marie 2020 London : Institute of Physics Publ.
• A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors
  Campos, Susana ; Matulonis, Ursula ; Berlin, Suzanne ; Horowitz, Neil ; Liu, Joyce ; Krasner, Carolyn ; Hang, Lee ; Zarwan, Corrine ; Barry, William ; Colella, Tina ; Whalen, Christen ; Shoni, Melina ; Lundquist, Christine ; Birrer, Michael J. ; Penson, Richard
• First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
  Takahashi, Shunji ; Oridate, Nobuhiko ; Tanaka, Kaoru ; Shimizu, Yasushi ; Fujimoto, Yasushi ; Matsumoto, Koji ; Yokota, Tomoya ; Yamazaki, Tomoko ; Takahashi, Masanobu ; Ueda, Tsutomu ; Hanai, Nobuhiro ; Yamaguchi, Hironori ; Hara, Hiroki ; Yoshizaki, Tomokazu ; Yasumatsu, Ryuji ; Nakayama, Masahiro ; Shiga, Kiyoto ; Fujii, Takashi ; Mitsugi, Kenji ; Takahashi, Kenichi ; Nohata, Nijiro ; Gumuscu, Burak ; Swaby, Ramona F. ; Tahara, Makato
• Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)
  Shoji, Tadahiro ; Takatori, Eriko ; Nagasawa, Takayuki ; Kagabu, Masahiro ; Baba, Tsukasa ; Shigeto, Tatsuhiko ; Matsumura, Yukiko ; Shimizu, Dai ; Terada, Yukihiro ; Seino, Manabu ; Ohta, Tsuyoshi ; Nagase, Satoru ; Shigeta, Shogo ; Tokunaga, Hideki ; Shimada, Muneaki ; Kaiho-Sakuma, Michiko ; Furukawa, Shigenori ; Soeda, Shu ; Watanabe, Takafumi ; Takahashi, Fumiaki ; Yokoyama, Yoshihito
• Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
  Niizeki, Takashi ; Tokunaga, Takayuki ; Takami, Yuko ; Wada, Yoshiyuki ; Harada, Masaru ; Shibata, Michihiko ; Nakao, Kazuhiko ; Sasaki, Ryu ; Hirai, Fumihito ; Shakado, Satoshi ; Yoshizumi, Tomoharu ; Itoh, Shinji ; Yatsuhashi, Hiroshi ; Bekki, Shigemune ; Ido, Akio ; Mawatari, Seiichi ; Honda, Koichi ; Sugimoto, Rie ; Senju, Takeshi ; Takahashi, Hirokazu ; Kuwashiro, Takuya ; Maeshiro, Tatsuji ; Nakamuta, Makoto ; Aratake, Yoshifusa ; Yamashita, Tsutomu ; Otsuka, Yuichiro ; Matsumoto, Shuichi ; Sohda, Tet
• Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study
  Akli, Assya ; Girard, Nicolas ; Fallet, Vincent ; Rousseau-Bussac, Gaelle ; Gounant, Valérie ; Friard, Sylvie ; Trédaniel, Jean ; Dujon, Cécile ; Wislez, Marie ; Duchemann, Boris ; Giroux-Leprieur, Etienne
• First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
  Kato, Ken ; Doki, Yuichiro ; Ogata, Takashi ; Motoyama, Satoru ; Kawakami, Hisato ; Ueno, Masaki ; Kojima, Takashi ; Shirakawa, Yasuhiro ; Okada, Morihito ; Ishihara, Ryu ; Kubota, Yutaro ; Amaya-Chanaga, Carlos ; Chen, Tian ; Matsumura, Yasuhiro ; Kitagawa, Yuko
• Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer’s Perspective
  Qu, Tingting ; Zhang, Shujing ; Zhong, Yichen ; Meng, Yang ; Guo, He ; Joo, Seongjung ; Enzinger, Peter C.
• Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)
  Dragovich, T. ; Baker, A. F. ; Bolejack, V. ; Burris, H. ; Crowley, J. ; Dayyani, F. ; Hidalgo, M. ; Hoff, D. D. Von ; Laheru, D. ; Raghunand, N. ; Ritch, P. ; Rosen, P. ; Seng, J. ; Smith, L.
• Cost-effectiveness analysis of sintilimab plus bevacizumab biosimilar compared with lenvatinib as the first-line treatment of unresectable or metastatic hepatocellular carcinoma
  Zhou, Ting ; Wang, Xintian ; Cao, Yingdan ; Yang, Lan ; Wang, Zijing ; Ma, Aixia ; Li, Hongchao
• A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice
  Liu, Yanxia ; Gao, Yuan ; Wang, Ying ; Zhao, Cong ; Zhang, Zhiyun ; Li, Baolan ; Zhang, Tongmei
• Risk factors for severe immune-related adverse events after first-line pembrolizumab monotherapy or combination chemotherapy for non-small-cell lung cancer
  Sumi, Toshiyuki ; Koshshino, Yuta ; Sekikawa, Motoki ; Nagahisa, Yuta ; Matsuura, Keigo ; Shijubou, Naoki ; Kamada, Koki ; Watanabe, Hiroki ; Michimata, Haruhiko ; Nagayama, Daiki ; Tanaka, Yusuke ; Yamada, Yuichi ; Chiba, Hirofumi
• Determinants of therapy failure among adults on first-line antiretroviral therapy in Asmara, Eritrea: a multicenter retrospective matched case–control study
  Mengistu, Samuel Tekle ; Ghebremeskel, Ghirmay Ghebrekidan ; Ghebrat, Hermon Berhe ; Achila, Oliver Okoth ; Yohannes, Nahom Asmerom ; Ghebrenegus, Amon Solomon ; Wendmhuney, Filmon Ghebretsadik ; Yeibyo, Naod ; Andegiorgish, Amanuel Kidane ; Mesfin, Araia Berhane ; Leake, Negassi
• Conditions for Workplace Learning as a New First-Line Manager in Elderly Care
  Wastesson, Karin ; Fogelberg Eriksson, Anna ; Nilsson, Peter ; Gustavsson, Maria
• A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada
  Chatterjee, Anuja ; Wetering, Gijs van de ; Goeree, Ron ; Owen, Carolyn ; Desbois, Anne Marie ; Barakat, Stephane ; Manzoor, Beenish S. ; Sail, Kavita